Markus Matilainen
PhD
Turku PET Centre manmat@utu.fi +358 29 450 4739 +358 50 472 8469 Itäinen Pitkäkatu 4 Turku ORCID identifier: https://orcid.org/0000-0002-5597-2670 |
Areas of expertise
Statistics; Biostatistics; Blind Source Separation
Statistics; Biostatistics; Blind Source Separation
Publications
- Stationary subspace analysis based on second-order statistics (2024)
- Journal of Computational and Applied Mathematics
(A1 Refereed original research article in a scientific journal) - Synaptic density in multiple sclerosis: An in vivo study using [11C]UCB-J-PET imaging (2024)
- Multiple Sclerosis
(Abstract) - TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)
- Multiple Sclerosis
(Poster) - Adenosine A2A receptor availability in cerebral gray and white matter of patients with Parkinson's disease (2023)
- Parkinsonism and Related Disorders
(A1 Refereed original research article in a scientific journal) - Akillesjännerepeämien maantieteelliset erot esiintyvyydessä ja hoitomuodoissa Suomessa vuosina 1997-2019 – maanlaajuinen tutkimus (2023)
- Suomen ortopedia ja traumatologia
(D1 Article in a professional journal) - Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)
- Journal of Neurology, Neurosurgery and Psychiatry
(A1 Refereed original research article in a scientific journal) - Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of Neurology
(A1 Refereed original research article in a scientific journal) - Olkaluun yläosan murtumien ilmaantuvuuden ja hoitomenetelmien alueelliset erot Suomessa 1997-2019 (2023)
- Suomen ortopedia ja traumatologia
(D1 Article in a professional journal) - PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- Journal of Neurology
(B1 Non-refereed article in a scientific journal)



